387 related articles for article (PubMed ID: 33848519)
1. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNAs as potential therapeutic targets in breast cancer.
Tomar D; Yadav AS; Kumar D; Bhadauriya G; Kundu GC
Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194378. PubMed ID: 31048026
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
7. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
9. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions.
McCabe EM; Rasmussen TP
Semin Cancer Biol; 2021 Oct; 75():38-48. PubMed ID: 33346133
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M; Taheriazam A; Orouei S; Fallah S; Sanaei A; Hejazi ES; Kakavand A; Rezaei S; Heidari H; Behroozaghdam M; Daneshi S; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Oct; 154():113609. PubMed ID: 36037786
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
14. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
Zhang X; Yang H
Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
[TBL] [Abstract][Full Text] [Related]
15. The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity.
Cao MX; Jiang YP; Tang YL; Liang XH
Oncotarget; 2017 Feb; 8(7):12472-12483. PubMed ID: 27992370
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
17. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
[TBL] [Abstract][Full Text] [Related]
18. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.
Wang JY; Yang Y; Ma Y; Wang F; Xue A; Zhu J; Yang H; Chen Q; Chen M; Ye L; Wu H; Zhang Q
Biomed Pharmacother; 2020 Jan; 121():109627. PubMed ID: 31810120
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.
Nandy SB; Gangwani L; Nahleh Z; Subramani R; Arumugam A; de la Rosa JM; Lakshmanaswamy R
Future Oncol; 2015; 11(6):983-95. PubMed ID: 25760978
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
Han Y; Hu H; Zhou J
Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]